Atlas Trials

Bioequivalence Test for Risperdal 2mg of Janssen Korea

Clinical trial NCT02012049 · COMPLETED

Trial details

NCT number
NCT02012049
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-08-01
Primary completion
2009-08-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.